MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment Read more
NIH Awards Allele with Grant for the Development of Nanoantibody Therapies for Treating Sepsis Read more
MaaT Pharma Announces First Patient Dosed in Phase 2 Clinical Trial of Lead Product MaaT013 Read more
Sandoz announces global resolution of biosimilar adalimumab patent disputes, securing patient access Read more